Shepherd James C, Jacobson Lisa P, Qiao Wei, Jamieson Beth D, Phair John P, Piazza Paolo, Quinn Thomas C, Margolick Joseph B
School of Medicine, Johns Hopkins University, MD, USA.
J Infect Dis. 2008 Oct 15;198(8):1104-12. doi: 10.1086/591623.
We examined the emergence of CXCR4 (i.e., X4) tropism in 67 male human immunodeficiency virus type 1 (HIV-1) seroconverters from the Multicenter AIDS Cohort Study (MACS) who were selected to reflect the full spectrum of rates of HIV-1 disease progression. A mean of 10 serial samples per donor were evaluated by a laboratory-validated, commercially available assay to determine phenotypic coreceptor use. A total of 52% of men had dual- or mixed-tropic HIV-1 detected at 1 or more of the time points tested. Use of X4 by HIV-1 was detected more frequently among men who developed AIDS (defined as a CD4(+) T cell count of <200 cells/muL and/or an AIDS-defining illness) < or =11 years after seroconversion than among those who did not (P = .005), as well as among men who exhibited a total T cell count decline (i.e., a CD3(+) inflection point), compared with those who did not (P = .03). For men in whom both X4 virus and an inflection point were detected, emergence of X4 virus preceded the inflection point by a median of 0.83 years. The median CD4(+) T cell count at first detection of X4 viruses before the onset of AIDS was 475 cells/microL. We conclude that HIV-1 variants that used X4 frequently emerged at high CD4(+) T cell counts and may contribute to the decrease in T cell numbers during late HIV-1 infection.
我们在多中心艾滋病队列研究(MACS)的67名男性1型人类免疫缺陷病毒(HIV-1)血清转化者中,研究了CXCR4(即X4)嗜性的出现情况,这些血清转化者被挑选出来以反映HIV-1疾病进展率的全谱。通过实验室验证的商用检测方法,对每个供体平均10份连续样本进行评估,以确定表型共受体的使用情况。在测试的1个或更多时间点,共52%的男性检测到具有双嗜性或混合嗜性的HIV-1。在血清转化后<或=11年发生艾滋病(定义为CD4(+) T细胞计数<200个细胞/μL和/或一种艾滋病定义疾病)的男性中,HIV-1使用X4的情况比未发生艾滋病的男性更频繁(P = .005),在出现总T细胞计数下降(即CD3(+)拐点)的男性中,也比未出现的男性更频繁(P = .03)。对于同时检测到X4病毒和拐点的男性,X4病毒的出现比拐点提前的中位数为0.83年。在艾滋病发病前首次检测到X4病毒时,CD4(+) T细胞计数的中位数为475个细胞/μL。我们得出结论,使用X4的HIV-1变体常在CD4(+) T细胞计数较高时频繁出现,并可能导致HIV-1感染后期T细胞数量减少。